Sterling Capital Management LLC Replimune Group, Inc. Transaction History
Sterling Capital Management LLC
- $6.45 Trillion
- Q1 2025
A detailed history of Sterling Capital Management LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 1,293 shares of REPL stock, worth $10,602. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,293
Previous 2,109
38.69%
Holding current value
$10,602
Previous $25.5 Million
50.64%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding REPL
# of Institutions
172Shares Held
78.5MCall Options Held
69.4KPut Options Held
216K-
Baker Bros. Advisors LP New York, NY11MShares$90.6 Million1.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$89 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA4.9MShares$40.2 Million5.02% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$38.7 Million0.0% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$32.1 Million9.21% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $404M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...